3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:千円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

2,823,367

2,603,703

売掛金

463,933

336,054

有価証券

1,118,245

3,904,102

商品及び製品

132,991

127,359

仕掛品

61,118

69,659

原材料及び貯蔵品

76,248

79,848

その他

220,821

213,173

貸倒引当金

283

4,539

流動資産合計

4,896,441

7,329,361

固定資産

 

 

有形固定資産

 

 

建物及び構築物

58,819

61,160

減価償却累計額

31,407

36,579

建物及び構築物(純額)

27,411

24,581

機械装置及び運搬具

199,729

239,071

減価償却累計額

57,552

92,423

機械装置及び運搬具(純額)

142,176

146,648

工具、器具及び備品

124,947

196,559

減価償却累計額

52,823

85,379

工具、器具及び備品(純額)

72,124

111,179

有形固定資産合計

241,713

282,409

無形固定資産

 

 

のれん

8,139

5,426

その他

18,699

8,421

無形固定資産合計

26,838

13,847

投資その他の資産

 

 

投資有価証券

4,403,537

1,914,189

繰延税金資産

55,322

59,155

その他

55,539

58,402

貸倒引当金

8,637

5,049

投資その他の資産合計

4,505,762

2,026,697

固定資産合計

4,774,314

2,322,954

資産合計

9,670,755

9,652,315

 

 

 

 

(単位:千円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

買掛金

131,109

141,808

未払金

101,159

124,212

未払法人税等

24,796

25,537

契約負債

42,437

40,672

前受金

113,602

116,629

賞与引当金

11,080

8,710

その他

216,399

159,663

流動負債合計

640,585

617,234

固定負債

 

 

繰延税金負債

35,206

176,741

資産除去債務

9,081

9,125

その他

935

2,487

固定負債合計

45,223

188,354

負債合計

685,808

805,589

純資産の部

 

 

株主資本

 

 

資本金

2,688,926

2,720,149

資本剰余金

6,244,884

6,276,107

利益剰余金

58,294

533,398

自己株式

916

916

株主資本合計

8,991,188

8,461,940

その他の包括利益累計額

 

 

その他有価証券評価差額金

13,677

325,433

為替換算調整勘定

7,435

59,352

その他の包括利益累計額合計

6,242

384,785

純資産合計

8,984,946

8,846,726

負債純資産合計

9,670,755

9,652,315

 

E2758549780株式会社リプロセルReproCELL Incorporated通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse497802026-05-14497802026-03-31497802025-04-012026-03-31497802025-03-31497802024-04-012025-03-31497802024-03-31497802026-03-31jpcrp_cor:ReportableSegmentsMember497802026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember497802025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember497802025-04-012026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember497802025-03-31jpcrp_cor:ReportableSegmentsMember497802025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember497802024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember497802024-04-012025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember497802026-03-31tse-acedjpfr-49780:ResearchSupportBusinessReportableSegmentsMember497802026-03-31tse-acedjpfr-49780:MedicalBusinessReportableSegmentsMember497802025-04-012026-03-31tse-acedjpfr-49780:ResearchSupportBusinessReportableSegmentsMember497802025-04-012026-03-31tse-acedjpfr-49780:MedicalBusinessReportableSegmentsMember497802025-03-31tse-acedjpfr-49780:ResearchSupportBusinessReportableSegmentsMember497802025-03-31tse-acedjpfr-49780:MedicalBusinessReportableSegmentsMember497802024-04-012025-03-31tse-acedjpfr-49780:ResearchSupportBusinessReportableSegmentsMember497802024-04-012025-03-31tse-acedjpfr-49780:MedicalBusinessReportableSegmentsMember497802026-03-31jpcrp_cor:ReconcilingItemsMember497802025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember497802025-03-31jpcrp_cor:ReconcilingItemsMember497802024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember497802025-03-31jppfs_cor:SubscriptionRightsToSharesMember497802024-04-012025-03-31jppfs_cor:ShareholdersEquityMember497802024-04-012025-03-31jppfs_cor:CapitalStockMember497802026-03-31jppfs_cor:ShareholdersEquityMember497802026-03-31jppfs_cor:CapitalStockMember497802026-03-31jppfs_cor:CapitalSurplusMember497802026-03-31jppfs_cor:RetainedEarningsMember497802024-04-012025-03-31jppfs_cor:CapitalSurplusMember497802024-04-012025-03-31jppfs_cor:RetainedEarningsMember497802024-04-012025-03-31jppfs_cor:TreasuryStockMember497802024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember497802024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember497802024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember497802024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMember497802024-03-31jppfs_cor:ShareholdersEquityMember497802024-03-31jppfs_cor:CapitalStockMember497802024-03-31jppfs_cor:CapitalSurplusMember497802024-03-31jppfs_cor:RetainedEarningsMember497802024-03-31jppfs_cor:TreasuryStockMember497802024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember497802024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember497802025-03-31jppfs_cor:CapitalSurplusMember497802026-03-31jppfs_cor:TreasuryStockMember497802026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember497802026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember497802026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember497802025-04-012026-03-31jppfs_cor:ShareholdersEquityMember497802025-04-012026-03-31jppfs_cor:CapitalStockMember497802025-04-012026-03-31jppfs_cor:CapitalSurplusMember497802025-04-012026-03-31jppfs_cor:RetainedEarningsMember497802025-04-012026-03-31jppfs_cor:TreasuryStockMember497802025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember497802025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember497802025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember497802025-03-31jppfs_cor:ShareholdersEquityMember497802025-03-31jppfs_cor:CapitalStockMember497802025-03-31jppfs_cor:RetainedEarningsMember497802025-03-31jppfs_cor:TreasuryStockMember497802025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember497802025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember497802025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember497802024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember497802024-03-31jppfs_cor:SubscriptionRightsToSharesMemberxbrli:pureiso4217:JPY